51.64
price down icon0.31%   -0.16
after-market Dopo l'orario di chiusura: 51.64
loading

Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie

pulisher
Nov 15, 2024

Perceptive Advisors LLC Increases Stake in Soleno Therapeutics I - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Objective long/short (SLNO) Report - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 14, 2024

Soleno Therapeutics Announces Oral Presentations featuring - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Avoro Capital Advisors LLC Increases Stake in Soleno Therapeutics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Soleno Therapeutics' SWOT analysis: rare disease stock poised for FDA decision - Investing.com Australia

Nov 13, 2024
pulisher
Nov 12, 2024

Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation - Yahoo Finance

Nov 12, 2024
pulisher
Nov 11, 2024

HC Wainwright Reiterates Buy Rating for Soleno Therapeutics (NASDAQ:SLNO) - MarketBeat

Nov 11, 2024
pulisher
Nov 08, 2024

Companies Like Soleno Therapeutics (NASDAQ:SLNO) Can Afford To Invest In Growth - Simply Wall St

Nov 08, 2024
pulisher
Nov 07, 2024

Harbor Capital Advisors Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Soleno Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Capnia Inc stock soars to 52-week high, hits $58 mark - Investing.com

Nov 06, 2024
pulisher
Nov 04, 2024

(SLNO) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 04, 2024
pulisher
Nov 04, 2024

Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) Target Price at $69.86 - Defense World

Nov 04, 2024
pulisher
Nov 03, 2024

Emerald Advisers LLC Grows Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $73.00 at Oppenheimer - Defense World

Nov 01, 2024
pulisher
Nov 01, 2024

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Nov 01, 2024
pulisher
Oct 29, 2024

Soleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week High Following Analyst Upgrade - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stake Boosted by Allspring Global Investments Holdings LLC - Defense World

Oct 28, 2024
pulisher
Oct 28, 2024

Capnia Inc stock soars to 52-week high of $56.89 amid robust growth By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 28, 2024

Soleno Therapeutics shares remain Outperform as analyst lifts price target on updated sales projections - Investing.com Australia

Oct 28, 2024
pulisher
Oct 28, 2024

Soleno Therapeutics (NASDAQ:SLNO) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Capnia Inc stock soars to 52-week high of $56.89 amid robust growth - Investing.com India

Oct 28, 2024
pulisher
Oct 28, 2024

Oppenheimer Boosts Soleno Therapeutics (NASDAQ:SLNO) Price Target to $73.00 - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Soleno Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewswire

Oct 28, 2024
pulisher
Oct 24, 2024

(SLNO) Technical Data - Stock Traders Daily

Oct 24, 2024
pulisher
Oct 21, 2024

Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D. - GlobeNewswire

Oct 21, 2024
pulisher
Oct 18, 2024

TriMas, Soleno Therapeutics, Ring Energy, and More Stocks See Action From Activist Investors - Barron's

Oct 18, 2024
pulisher
Oct 17, 2024

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA - MSN

Oct 17, 2024
pulisher
Oct 16, 2024

Prader-Willi Syndrome Market to Drive Growth with Prominent - openPR

Oct 16, 2024
pulisher
Oct 16, 2024

Soleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCR - Insider Monkey

Oct 16, 2024
pulisher
Oct 16, 2024

Soleno Therapeutics Inc (SLNO)’s stock price in review: A technical analysis - US Post News

Oct 16, 2024
pulisher
Oct 15, 2024

Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment - Insider Monkey

Oct 15, 2024
pulisher
Oct 14, 2024

The Potential Rise in the Price of Soleno Therapeutics Inc (SLNO) following insiders activity - Knox Daily

Oct 14, 2024
pulisher
Oct 11, 2024

Soleno Therapeutics (NASDAQ:SLNO) Trading Up 6.4%Time to Buy? - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Insider’s View: Deciphering Soleno Therapeutics Inc (SLNO)’s Financial Health Through Ratios - The Dwinnex

Oct 11, 2024
pulisher
Oct 10, 2024

Carlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc. - GuruFocus.com

Oct 10, 2024
pulisher
Oct 10, 2024

Taking a look at what insiders are doing to gauge the Soleno Therapeutics Inc (SLNO)’s direction - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Soleno Therapeutics Nears FDA Decision: Strong Buy Targeting PWS Hyperphagia Treatments - Seeking Alpha

Oct 10, 2024
pulisher
Oct 10, 2024

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Holdings Lifted by The Manufacturers Life Insurance Company - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Soleno Therapeutics Inc [SLNO] Revenue clocked in at $0.00 million, up 29.12% YTD: What’s Next? - The DBT News

Oct 09, 2024
pulisher
Oct 09, 2024

Recent Price Trend in Soleno Therapeutics (SLNO) is Your Friend, Here's Why - Yahoo Canada Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis - RTTNews

Oct 09, 2024
pulisher
Oct 08, 2024

FDA leans away from advisory meeting for Soleno's PWS drug By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Laidlaw maintains buy rating, $75 target on Soleno Therapeutics By Investing.com - Investing.com Australia

Oct 08, 2024
pulisher
Oct 08, 2024

Soleno shares set to surge on positive FDA update - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

Capnia Inc stock soars to 52-week high, hits $56.14 - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Stifel maintains Buy rating on Soleno Therapeutics shares - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Baird reiterates price target on Soleno shares, positive on FDA update - Investing.com

Oct 08, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):